Home › Trial NCT07160647
The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)
- Trial IDNCT07160647
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorSir Run Run Shaw Hospital
- Enrollment29
- Start date2025-08-20
- ConditionsdMMR/MSI-H-type Rectal Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.